CWM
ABUS icon

CIBC World Markets’s Arbutus Biopharma ABUS Stock Holding History

CIBC World Markets’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$48.2K Buy
+10,015
New +$45K ﹤0.01% 1197
2025
Q2 		$57.6K Sell
18,653
-13,764
-42% -$45.7K ﹤0.01% 1460
2025
Q1 		$113K Buy
32,417
+18,745
+137% +$62.5K ﹤0.01% 1581
2024
Q4 		$44.7K Buy
+13,672
New +$50.3K ﹤0.01% 1265

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

CIBC World Markets's ABUS Position: Q4 2025 in Review

CIBC World Markets opened a new position in Arbutus Biopharma (ABUS) in Q4 2025: 10,015 shares worth $48.2K. The stake represents ﹤0.01% of the portfolio and ranks #1197 among its holdings. This is a return to the name: CIBC World Markets previously reported a position in ABUS as recently as Q2 2025.

CIBC World Markets first reported a position in ABUS in Q4 2024 and has held it in 4 quarters since. The position peaked at $113K in Q1 2025. 172 funds tracked by Wall St. Rank hold ABUS as of Q4 2025.

  • CIBC World Markets held 10,015 shares of Arbutus Biopharma worth $48.2K as of Q4 2025.
  • Arbutus Biopharma was a new CIBC World Markets position in Q4 2025.
  • Arbutus Biopharma made up ﹤0.01% of CIBC World Markets's portfolio in Q4 2025, its #1197 holding.
  • CIBC World Markets first reported a position in Arbutus Biopharma in Q4 2024 and has held it in 4 quarters since.
  • CIBC World Markets's Arbutus Biopharma position peaked at $113K in Q1 2025.
  • 172 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q4 2025.

Based on CIBC World Markets's 13F filing for Q4 2025, filed 12 Feb 2026.